FindTrial
Sign In

Transrectal contrast enhanced ultrasound targeted biopsy for prostate cancer detection in patients with different levels of PSA

Transrectal contrast enhanced ultrasound targeted biopsy for prostate cancer detection in patients with different levels of PSA

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015917
Enrollment
Unknown
Registered
2018-04-28
Start date
2018-04-28
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

Gold Standard:Pathological examination
Index test:Transrectal&#32
contrast&#32
enhanced&#32
ultrasound&#32
targeted&#32
biopsy

Sponsors

Central Hospital of Panyu District, Guangzhou
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
50 Years to 90 Years

Inclusion criteria

Inclusion criteria: Male with elevated PSA levels, age > 50years

Exclusion criteria

Exclusion criteria: With underlying diseases who can not tolerate an operation or have absolute contraindication to surgery

Design outcomes

Primary

MeasureTime frame
Prostate cancer detection rate;biopsy cores;Positive rate of single core;Gleason scores;Complication;—

Countries

China

Contacts

Public Contact???

Central Hospital of Panyu District, Guangzhou

409300282@qq.com+86 13922285579

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026